The US Orthopedic Devices Market evolution is closely tied to the national push toward value-based healthcare and improved patient mobility. With healthcare spending projected to reach USD 6 trillion by 2027, the demand for cost-effective orthopedic interventions has never been higher. Orthopedic devices address this need by restoring function and reducing long-term disability. The market's expansion from USD 10.5 billion to over USD 16.5 billion by 2035 reflects strong confidence in the segment's ability to deliver measurable clinical and economic value.
Explore detailed forecasts at
US Orthopedic Devices Market, which highlights how the plastic material segment is expected to grow from USD 2.1 billion in 2024 to USD 3.2 billion by 2035. Trauma fixation devices remain essential for fracture management, valued at USD 0.982 billion in 2024. Hospitals continue to hold the largest end-user share due to their capacity for complex, multi-disciplinary procedures requiring extensive facilities.
Moreover, the COVID-19 pandemic created a significant backlog in elective orthopedic surgeries, which is now driving a surge in procedure volumes as healthcare systems recover. This pent-up demand is expected to sustain elevated market growth rates in the near term. Manufacturers are scaling production capacity to meet this demand while maintaining stringent quality standards.
FAQs
Q1: How did the pandemic affect the orthopedic devices market?
A: It created a substantial backlog in elective surgeries, which is now driving a surge in procedure volumes and device demand.
Q2: Which material segment is growing fastest?
A: The plastic segment is expanding significantly, projected to grow from USD 2.1 billion in 2024 to USD 3.2 billion by 2035.
Q3: What is the role of hospitals in this market?
A: Hospitals hold the largest end-user share, attributed to their extensive facilities and ability to perform complex surgeries.
Related Reports
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek